Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

The Start of Internal Audit in Pharmaceutical Companies

Explore and uncover the key aspects of efficient pharmaceutical internal audit processes, while also delving into the valuable ISO 19011 guidelines. Understand the importance of thorough audit program preparation, as it is essential for achieving success in your auditing efforts
  • Audit and Inspection, Quality Management System
Establishing a robust pharma internal audit program ensures that processes remain efficient, risks are mitigated, and standards such as Good Manufacturing Practices (GMP) are maintained.

How to predict for the formation of NDSRIs ?

The detection of N-nitrosamine impurities in medicines and the increasing presence of nitrosamine drug substance-related impurities (NDSRIs) have presented significant challenges for both drug manufacturers and regulatory agencies.
  • Blog, Nitrosamine
Female pharmacist staring at packaged pharmaceutical drugs in her hands

Reprocess and Rework in Pharma: A Comprehensive Guide

This comprehensive guide on reprocess and rework in pharma explains their definitions, highlights key differences, and offers practical tips for successful implementation. Stay compliant and maintain product integrity with our expert insights.
  • Change Management, Quality Management System
Implementing effective reprocess and rework strategies is essential for maintaining compliance and ensuring product quality.

How to Manage Scale-Up Change Controls: A Step-by-Step Guide

Managing scale-up change controls is essential for ensuring a seamless transition in pharmaceutical manufacturing. This guide provides actionable steps, a checklist, and tips to handle scale-up changes effectively.
  • Change Management, Quality Management System
Detailed documentation is a cornerstone of effective scale-up change control.

What is the CPCA Category for Nitrosamine?

The CPCA for Nitrosamine simplifies the complex process of assessing nitrosamine impurities by categorizing them based on carcinogenic risk.
  • Nitrosamine
Multiethnic team of pharmaceutical researcher studying a new drug for diabetes

5 Steps to Unlocking Maximum Efficiency with Quality 4.0

Quality 4.0 integrates AI and ML into Quality Management Systems, offering predictive insights and automation that redefine operational landscapes and minimize quality risks.
  • eQMS, Quality Management System
With Quality 4.0, data is continuously collected and analyzed.

2 Major Shifts in ICH Q9 You Should Know

The updated ICH Q9 guideline urges pharmaceutical companies to adopt proactive quality risk management strategies. Discover how this shift enhances decision-making and ensures product quality.
  • Quality Management System
The updated ICH Q9 guideline reflects advancements in risk management and evolving industry needs.

Continuous Process Verification: A Modern Method for Product QA

Continuous Process Verification (CPV) is transforming manufacturing by ensuring real-time product quality. Explore its benefits, the role of data analytics, and how it aligns with regulatory standards in this comprehensive guide.
  • Process Validation, Validation and Qualification
Continuous Process Verification is a method of quality assurance that involves the real-time monitoring of manufacturing processes.

Use the Full Potential of Veeva: A Introduction for Pharma and Biotech Companies

Uncover the numerous advantages that Veeva offers specifically for the pharmaceutical and biotechnology sectors by reading this insightful whitepaper. Delve into the ways in which its software-as-a-service (SaaS) solutions enhance operational efficiency and significantly enhance regulatory compliance within these industries.
  • Computerized System Validation
As a SaaS platform, Veeva regularly updates its features and capabilities without requiring downtime or costly upgrades.

What the Salesforce and Veeva Split Means for Pharmaceutical Companies

The end of the Salesforce and Veeva partnership is a game-changer for pharmaceutical companies. With the September 2025 deadline approaching, learn how to avoid operational disruptions, ensure compliance, and stay ahead of the competition by transitioning effectively.
  • Computerized System Validation
Pharmaceutical companies must adhere to stringent global and local regulations, such as FDA 21 CFR Part 11 or EU regulations on electronic records and signatures.